Abstract
Neuronal injury resulting from glutamate receptor-mediated excitotoxicity has been implicated in a wide spectrum of neurological disorders. Following dramatic results in the preclinical setting, anti-excitotoxic neuroprotective agents have been used in clinical trials for stroke and head injury, but the results have generally been unsuccessful. Hence, alternative targets in the excitotoxic cascade appear to be required. Poly(ADP-ribosyl)ation has been linked to the pathogenesis of numerous disorders of the CNS, including excitotoxicity and ischemic injury. A presumed cascade of glutamate receptor activation leading to excessive free radical formation, DNA damage and then overactivation of PARP-1 is based on studies with drugs that block these various steps. Along this classical view, experiments in our laboratory have shown that the intracellular depletion of ATP and NAD induced by PARP-1 overactivation leads to necrotic cell death in ischemic and excitotoxic models and that PARP-1 inhibitors are protective against necrotic but not apoptotic neuronal death. Therefore, it appears reasonable to propose PARP-1 inhibitors as useful therapeutic agents in pathological brain conditions where necrosis predominates.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Neuronal Death
- Middle Cerebral Artery Occlusion
- Necrotic Cell Death
- Cereb Blood Flow
- Apoptotic Neuronal Death
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Olney JW. Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol 1990; 30:47–71.
Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurological disorders. N Engl J Med 1994; 330:613–622.
Doble A. The role of excitotoxicity in neurodegenerative disease: Implications for therapy. Pharmacol Ther 1999; 81:163–221.
Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79:1431–1568.
Meldrum BS. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J Nutr 2000; 130:1007S–1015S.
Lee J-M, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999; 399(supp.):A7–A14.
Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 1999; 22:391–397.
Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002; 33:2123–2136.
Grotta J. Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke 2002; 33:306–307.
Aarts MM, Tymianski M. Novel treatment of excitotoxicity: Targeted disruption of intracellular signalling from glutamate receptors. Biochem Pharmacol 2003; 66:877–886.
Berger NA. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 1985; 101:4–15.
Chiarugi A. Poly(ADP-ribose) polymerase: Killer or conspirator? The’ suicide hypothesis’ revisited. Trends Pharmacol Sci 2002; 23:122–129.
Shall S, de Murcia G. Poly(ADP-ribose) polymerase-1:What have we learned from the deficient mouse model? Mutat Res 2000; 450:1–15.
Szabó C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998; 19:287–298.
Pieper AA, Verma A, Zhang J et al. Poly(ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 1999; 20:171–181.
Yu S-W, Wang H, Poitras MF et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297:259–263.
Cosi C, Suzuki H, Milani D et al. Poly(ADP-ribose) polymerase: Early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res 1994; 39:38–46.
Zhang J, Dawson VL, Dawson TM et al. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994; 263:687–689.
Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999; 96:13978–13982.
Mandir AS, Poitras MF, Berliner AR et al. NMDA but not nonNMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase. J Neurosci 2000; 20:8005–8011.
Choi DW. Excitotoxic cell death. J Neurobiol 1992; 23:1261–1276.
Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990; 11:379–387.
Pellegrini-Giampietro DE, Peruginelli F, Meli E et al. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: Time-course and mechanisms. Neuropharmacology 1999; 38:1607–1619.
Nicoletti F, Bruno V, Copani A et al. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders? Trends Neurosci 1996; 19:267–271.
Eliasson MJL, Sampei K, Mandir AS et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997; 3:1089–1095.
Endres M, Wang Z-Q, Namura S et al. Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 1997; 17:1143–1151.
Goto S, Xue R, Sugo N et al. Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke 2002; 33:1101–1106.
Takahashi K, Greenberg JH, Jackson P et al. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1997; 17:1137–1142.
Meli E, Pangallo M, Baronti R et al. Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage. Toxicol Lett 2003; 193:153–162.
Chiarugi A, Meli E, Calvani M et al. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: Pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia. J Pharmacol Exp Ther 2003; 305:943–949.
Giovannelli L, Cozzi A, Guarnieri I et al. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: Differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors. J Cereb Blood Flow Metab 2002; 22:697–704.
Moroni F, Meli E, Peruginelli F et al. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 2001; 8:921–932.
Nicotera P, Lipton SA. Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab 1999; 19:583–591.
Wang KKW. Calpain and caspase: Can you tell the difference? Trends Neurosci 2000; 23:20–26.
Bowes J, Thiemermann C. Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the liver injury caused by ischaemia-reperfusion: A comparison with radical scavengers. Brit J Pharmacol 1998; 124:1254–1260.
Leist M, Single B, Castoldi AF et al. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185:1481–1486.
Gwag BJ, Lobner D, Koh J-Y et al. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience 1995; 68:615–619.
Martin LJ, Al-Abdulla NA, Brambrink AM et al. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998; 46:281–309.
Charriaut-Marlangue C, Aggoun-Zouaoui D, Represa A et al. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci 1996; 19:109–114.
Kaminski Schierle GS, Hansson O, Ferrando-May E et al. Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation. NeuroReport 1999; 10:3347–3351.
van Lookeren Campagne M, Gill R. Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischemia in the rat. Neurosci Lett 1996; 213:111–114.
Rosenblum WI. Histopathological clues to the pathways of neuronal death following ischemia/hypoxia. J Neurotrau 1997; 14:313–326.
MacManus JP, Hill IE, Preston E et al. Differences in DNA fragmentation following transient cerebral or decapitation ischemia in rats. J Cereb Blood Flow Metab 1995; 15:728–737.
Martinou J-C, Dubois-Dauphin M, Staple JK et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13:1017–1030.
Hara H, Friedlander RM, Gagliardini V et al. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94:2007–2012.
Namura S, Zhu J, Fink K et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998; 18:3659–3668.
Gottron FJ, Ying HS, Choi DW. Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol Cell Neurosci 1997; 9:159–169.
Okamoto M, Matsumoto M, Ohtsuki T et al. Internucleosomal DNA cleavage involved in ischemia-induced neuronal death. Biochem Biophys Res Commun 1993; 196:1356–1362.
Nitatori T, Sato N, Waguri S et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995; 15:1001–1011.
Colbourne F, Sutherland GR, Auer RN. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J Neurosci 1999; 19:4200–4210.
Simbulan-Rosenthal CM, Rosenthal DS, Iyer S et al. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J Biol Chem 1998; 273:13703–13712.
Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem Sci 1997; 22:299–306.
Cosi C, Colpaert F, Koek W et al. Poly(ADPribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res 1996; 729:264–269.
Meli E, Pangallo M, Picca R et al. Differential role of poly(ADP-ribose) polymerase-1 in apoptotic and necrotic neuronal death induced by mild or intense NMDA exposure in vitro. Mol Cell Neurosci 2004; 25:172–180.
Bonfoco E, Krainc D, Ankarcrona M et al. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxid/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995; 92:7162–7166.
Pieper AA, Walles T, Wei G et al. Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption. Mol Med 2000; 6:271–282.
Burkart V, Wang ZQ, Radons J et al. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 1999; 5:314–319.
Pieper AA, Brat DJ, Krug DK et al. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999; 96:3059–3064.
Leist M, Single B, Kunstle G et al. Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem Biophys Res Commun 1997; 17:518–522.
Ziegler M, Oei SL. A cellular survival switch: Poly(ADP-ribosyl)ation stimulates DNA repair and silences transcription. Bioessays 2001; 23:543–548.
Lee YJ, Shacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1999; 274:19792–19798.
Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997; 57:1835–1840.
Walisser JA, Thies RL. Poly(ADP-ribose) polymerase inhibition in oxidant-stressed endothelial cells prevents oncosis and permits caspase activation and apoptosis. Exp Cell Res 1999; 251:401–413.
Cole KK, Perez-Polo JR. Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H(2)O(2) injury. J Neurochem 2002; 82:19–29.
LaPlaca M, Raghupathi R, Verma A et al. Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat. J Neurochem 1999; 73:205–213.
Scovassi AI, Poirier GG. Poly(ADP-ribosylation) and apoptosis. Mol Cell Biochem 1999; 199:125–137.
Boulares AH, Yakovlev AG, Ivanova V et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 1999; 274:22932–22940.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Pellegrini-Giampietro, D.E., Chiarugi, A., Moroni, F. (2006). Poly(ADP-Ribose) Polymerase (PARP) and Excitotoxicity. In: Poly(ADP-Ribosyl)ation. Molecular Biology Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-36005-0_14
Download citation
DOI: https://doi.org/10.1007/0-387-36005-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-33371-7
Online ISBN: 978-0-387-36005-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)